Can special lenses plus eye drops stop Kids' myopia from getting worse?

NCT ID NCT06358755

Ongoing Disease control Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether combining special glasses (that create optical defocus) with low-dose atropine eye drops can better control myopia (nearsightedness) in children aged 7 to 12. Over 18 months, researchers will measure changes in eye prescription and eye length. The goal is to find a more effective way to slow myopia progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: low-dose atropine (0.01%) eye drops
What this could lead to: If successful, this combination approach could offer a more effective way to slow down worsening nearsightedness in children, potentially reducing the need for stronger glasses later.
What could go wrong: This is a relatively small, early-stage trial (112 children) and results may not apply to all ethnicities or ages. The atropine drops can cause side effects like light sensitivity or blurred near vision.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

myopia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MYOPIA

Contacts and locations

Locations

Centre for Myopia Research, The Hong Kong Polytechnic University and Department of Ophthalmology, The University of Hong Kong

Hong Kong, No postcode, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.